Loading clinical trials...
Loading clinical trials...
This is a Phase 2a double-blind, placebo-controlled study with two dose levels of A0001 given twice daily for 28 days. Potential subjects will be screened first to determine eligibility, after which t...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Penwest Pharmaceuticals Co.
NCT02497534 · Friedreich's Ataxia
NCT02316314 · Friedreich's Ataxia
NCT07095062 · Friedreich's Ataxia, Motor Disorders
NCT07444333 · Friedreich's Ataxia
NCT02415127 · Friedreich's Ataxia
The Children's Hospital of Philadelphia
Philadelphia, Pennsylvania
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions